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PSY42 BLEEDING DISORDERS, MENORRHAGIA AND IRON DEFICIENCY: AN EXAMINATION OF QUALITY OF LIFE
Horsman JR 1 , Rae CS 2 , Furlong W 2 , McGugan J 2 , Barr RD 2 , Lillicrap D 3 1 Health Utilities Inc, Dundas, ON, Canada, 2 McMaster University, Hamilton, ON, Canada, 3 Queen's University, Kingston, ON, Canada OBJECTIVES: Von Willebrand disease (VWD) is a bleeding disorder affecting about 1% of the general population. This study explored relationships between bleeding disorders, menorrhagia, iron deficiency and HRQL. It was hypothesized that females with bleeding disorders would have low HRQL associated with menorrhagia and iron deficiency. METHODS: All males and females with VWD, and females with other bleeding disorders, in the Canadian national registry, who were older than 12 years of age and literate in English or French, were eligible for survey in this cross-sectional population-based study. Measures included the Health Utilities Index Mark 3 utility scores of HRQL; abridged Clinical History Assessment Tool for menorrhagia; sociodemographic questions; and blood for serum ferritin. Iron deficiency was defined as serum ferritin 20 mcg/L. Statistical analyses included testing differences among groups of means using analysis of variance, and of proportions using chi-square. Statistical significance was set at the 5% level. RESULTS: 413 subjects participated. There was a significant difference (p 0.026) among mean HRQL scores for females with VWD (0.701), females with other bleeding disorders (0.783) and males with VWD (0.767). Among menstruating females (n 185), there was: no significant difference (p 0.108) in mean HRQL scores between females with VWD and females with other bleeding disorders; a high (p 0.001) prevalence of menorrhagia (44%) compared to controls (11%); a significant difference (p 0.001) in mean HRQL scores for those with / without (0.643 / 0.816) menorrhagia; and no association (p 0.740) between menorrhagia and iron deficiency. CONCLUSIONS: Females with VWD have lower HRQL than females with other bleeding disorders and males with VWD. Menorrhagia is prevalent and associated with lower HRQL, but not iron deficiency, among menstruating females with bleeding disorders. Future research should investigate better management of menorrhagia for improving HRQL.
PSY43 MAPPING THE ROLAND MORRIS DISABILITY QUESTIONNAIRE FOR BACK PAIN INTO UTILITY INDEX
Chuang LH, The UK BEAM Trial . York Trials Unit, University of York, York, UK OBJECTIVES: To develop the functions of mapping the 24-item Roland Morris Disability Questionnaire (RMDQ) for back pain into the EQ-5D and SF-6D utility index. METHODS: Data were obtained from the UK BEAM trial, a multi-centre randomised trial of physical treatments for back pain in primary care. A total of 1334 patients were recruited and completed a battery of questionnaires, including RMDQ, EQ-5D and SF-36v2 at the baseline, 1, 3 and 12-month follow-ups. The responses of SF-36v2 were converted into SF-6D using the published algorithm. Data were divided into two groups: one to estimate the mapping functions through regression methods and the other to validate the mapping functions. Both overall dataset and sub-datasets of each follow-up were examined separately RESULTS: Ordinary least square (OLS) regression with summary score of RMDQ as independent variable explained 27, 39, 46 and 53% of variance of observed EQ-5D scores for each follow-up, respectively. Based on the overall dataset, OLS regression explained 40 and 44 % of variance with the summary score and 18 items of RMDQ as independent variables, respectively. However, the mean absolute difference (MAD) of all above models was greater than 0.13. Meanwhile, models for mapping RMDQ into SF-6D explained only 1 to 4% of variance amongst all examined models and datasets. CONCLUSIONS: Based on the current findings, the score of RMDQ for back pain cannot be mapped into the SF-6D utility score. The possible cause could be the lack of over-lapping domains between two measures. The mapping of RMDQ into EQ-5D could be feasible but applied at the group level only. The correlation between RMDQ and EQ-5D increased when patients' pain condition improved. Consequently, the choice of input dataset, overall or subset, has a great impact on estimating functions. The finial selected dataset for mapping needs to be justified.
PSY44 LINGUISTIC VALIDATION OF HAEMOPHILIA-SPECIFIC PATIENT-RATED OUTCOMES (HAEMO-QOL, HAEM-A-QOL, HEMO-SAT) IN UP TO 32 LANGUAGES
Institute of Medical Psychology, München, Germany, 2 Novo Nordisk A/S, Søborg, Denmark, 3 MAPI Institute, Lyon, France Haemophilia is a congenital bleeding disorder with a prevalence of 1:10,000 inhabitants. Treatment of patients with haemophilia requires a substantial amount of economical and human resources, why patient-rated outcomes (PROs) such as Quality of Life (QoL) and treatment satisfaction (TS) are considered increasingly more important in this field. For the adequate assessment of PROs cross-culturally validated disease-specific instruments are necessary. OBJECTIVES: Linguistic validation of 3 haemophilia-specific PROs for the assessment of TS (Hemo-Sat) and QoL, both in children (Haemo-QoL: 3 age group versions for children 4-7, 8-12, 13-16 years and their parents) and in adults (Haem-A-QoL) in up to 32 languages. METHODS: For languages where no translation existed, the process was conducted by a specialist in each target country using the following standardized methodology: (1) two forward translations by professional translators, native speakers of the target language and fluent in English; (2) comparison and reconciliation of the translations by the specialist in the target country; (3) backward translation by a native English speaker; (4) comparison of source and backward version; (5) review by the developer for a selection of languages; creation of the different forms of the instrument; (6) review by a clinician. RESULTS: The Haemo-QoL was linguistically validated into 32 languages, Haem-A-QoL (n 29) and Hemo-Sat (n 19). Besides the challenge of ensuring conceptual equivalence with the original and cultural appropriateness, the translation process revealed 2 additional difficulties. When translating an expression, appropriate terms had to be found for each age group whilst maintaining consistency across all versions of the same language. CONCLUSIONS: The language versions of HaemoQoL, Haem-A-QoL and Hemo-Sat were established according to a rigorous translation methodology aiming to ensure conceptual equivalence across different language versions facilitating international comparison and pooling of data. The linguistic validation process is necessary before using PROs in international trials. France SA, Rungis, France OBJECTIVES: Severe Crohn's disease management includes anti-Tumour Necrosis Factor (anti-TNF) drugs. These drugs differ from the treatments used in early stages of the disease in terms of efficacy, safety and convenience. This can modify the impact of the disease and its treatment on patients' lives. The objective of the study was to develop a questionnaire assessing patients' satisfaction with anti-TNF treatments in Crohn's disease. METHODS: A literature review, 3 clinician interviews and 3 interviews with nurses were carried out as a preparation step. Semi-directive patient
PSY45 DEVELOPMENT OF A QUESTIONNAIRE TO EVALUATE TREATMENT SATISFACTION OF PATIENTS WITH SEVERE CROHN'S DISEASE: QUALITATIVE STEPS

